Increased levels of the tumor metabolite 5′-deoxy-5′-methylthioadenosine (MTA), stemming from a deficiency in the enzyme methylthioadenosine phosphorylase (MTAP), suppress T cell proliferation, activation, differentiation, and effector functions through modulation of the Akt pathway and interference with protein methylation. Here, MTAP is linked to neoplasm.